New cardiac ablation catheter integrates with 3D mapping system to advance the treatment of atrial fibrillation ABBOTT PARK, Ill., May 9, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced CE Mark of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, developed to make it easier for physicians to more effectively treat atrial fibrillation (AF), a […]
The new Confirm RX™ ICM automatically captures vital cardiac information and relays data to physicians via the myMerlin™ mobile app enabling remote monitoring of irregular heart rhythms ABBOTT PARK, Ill., May 8, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm Rx™ Insertable Cardiac Monitor (ICM), the […]
FreeStyle® Libre system eliminates routine finger sticks(1) for glucose measurements and requires no finger sticks for calibration Now reimbursed in France, the second largest market(2) for FreeStyle Libre globally First-of-its-kind product now has full or partial reimbursement across 13 countries in Europe, including Austria, Germany, Italy and Sweden PARIS, May 8, 2017 /PRNewswire/ — Abbott today […]
Research shows that staying nourished in the days and hours prior to a procedure can help patients prepare for and recover from surgery New Ensure® Surgery Immunonutrition Shake and Ensure® Pre-Surgery Clear Nutrition Drink are designed for hospitals implementing surgical guidelines for enhancing patient recovery ABBOTT PARK, Ill., April 26, 2017 /PRNewswire/ — More than […]
ABBOTT PARK, Ill. and WALTHAM, Mass., April 14, 2017 /PRNewswire/ — Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced today that the companies have agreed to amend the existing terms of their agreement for Abbott’s acquisition of Alere. Under the amended terms, Abbott will pay $51 per common share to acquire Alere, for a […]
Presented at ACC and published in Journal of American College of Cardiology, the CardioMEMS™ HF System offers sustained benefits for patients suffering from symptomatic heart failure Heart failure hospitalizations cut nearly in half and an average reduction of $10,500 in comprehensive health care costs six months following implant WASHINGTON, March 19, 2017 /PRNewswire/ — New […]
92.8% procedural success observed in reducing leaky heart valve 80.0% of those treated free from repeat heart failure re-hospitalization 85.9% of patients were discharged to home after two-day average hospital stay WASHINGTON, March 18, 2017 /PRNewswire/ — Abbott (NYSE: ABT) today announced favorable one-year outcomes from the largest study of real-world experience for the MitraClip […]
Results emphasize importance of proper vessel sizing and following current instructions for use for optimal clinical outcomes WASHINGTON, March 18, 2017 — Abbott today announced that data from the ABSORB III U.S. pivotal trial showed that Absorb, Abbott’s first-of-its-kind dissolving stent, had comparable efficacy and safety results to XIENCE, Abbott’s leading metallic drug-eluting stent, between […]
Oral Dydrogesterone has the potential to become new treatment of choice for an estimated 1.5 million women worldwide who undergo IVF treatment each year (1, 2) ABBOTT PARK, Ill., March 8, 2017 /PRNewswire/ — New study results published in Human Reproduction could pave the way for an additional treatment option for the estimated 1.5 million […]
Sensor EnabledTM tool complements the EnSite PrecisionTM cardiac mapping system and expands Abbott’s comprehensive advanced cardiac mapping and ablation portfolio ABBOTT PARK, Ill., March 1, 2017 — Abbott today announced U.S. Food and Drug Administration (FDA) approval of the FlexAbility™ Ablation Catheter, Sensor Enabled™ designed to improve the versatility and precision during cardiac ablation procedures […]